Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.

2-Methoxyestradiol (2-MeO-E(2)), a well-known nonpolar endogenous metabolite of 17beta-estradiol, has strong antiproliferative, apoptotic, and antiangiogenic actions in vitro and in vivo at pharmacologic concentrations. We determined in the present study whether 2-MeO-E(2) can enhance the anticancer actions of paclitaxel or vinorelbine (two commonly used microtubule-disrupting agents) in several human breast cancer cell lines, including the estrogen receptor-positive MCF-7 and T-47D cells and the receptor-negative MDA-MB-435s and MDA-MB-231 cells. 2-MeO-E(2) in combination with paclitaxel or vinorelbine exhibited a synergistic anticancer effect in these human breast cancer cells in vitro, and this synergistic effect was more pronounced when each of the drugs was used at relatively low concentrations. Additional experiments using female athymic BALB/c nu/nu mice showed that p.o. administration of 2-MeO-E(2) at 30 mg/kg body weight, once a week for 6 weeks, markedly enhanced the activity of paclitaxel or vinorelbine against the growth of the estrogen receptor-negative MDA-MB-231 human breast cancer xenografts in these animals. By contrast, combination of 2-MeO-E(2) with 5-fluorouracil only had a partial additive effect against the growth of these cell lines in culture, and no synergistic effect was observed. Interestingly, when doxorubicin was used in combination with 2-MeO-E(2), the antiproliferative effect of 2-MeO-E(2) was somewhat antagonized by doxorubicin when it was present at high concentrations. Our results showed that 2-MeO-E(2) at nontoxic or subtoxic doses selectively enhanced the effects of certain microtubule-disrupting agents (such as paclitaxel and vinorelbine) against the growth of the receptor-negative human breast cancer cells in culture and also in athymic nude mice.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.387.65.2PMID 15695378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate

  2004cited by this paper
• Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.

  2004cited by this paper
• Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action.

  2003cited by this paper
• The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

  2001cited by this paper
• Vinorelbine – a clinical review

  2000cited by this paper
• Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?

  1998cited by this paper
• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cited by this paper
• The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.

  1997cited by this paper
• Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

  1997cited by this paper
• Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth.

  1997cited by this paper
• Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site.

  1995cited by this paper
• Paclitaxel (taxol)

  1995cited by this paper
• The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

  1994cited by this paper
• Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells.

  1992cited by this paper
• Effects of 17β-Estradiol Metabolites on Cell Cycle Events in MCF-7 Cells

  1992cited by this paper
• The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells.

  1989cited by this paper
• Determination of cell number in monolayer cultures.

  1986cited by this paper

• Redox-Responsive Dendritic Copolymer-Drug Conjugates Enhance Therapeutic Mitophagy Through Coordinated Microtubule Destabilization for Synergistic Triple-Negative Breast Cancer Therapy.

  2025cites this paper
• The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.

  2022cites this paper
• Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers through an Intrinsic Apoptosis Pathway

  2020cites this paper
• The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling

  2020cites this paper
• Co-administration of paclitaxel and 2-methoxyestradiol using folate-conjugated human serum albumin nanoparticles for improving drug resistance and antitumor efficacy

  2020cites this paper
• Antiproliferative and antimetastatic properties of D-ring modified estrogen analogs on cervical cancer cell lines

  2018cites this paper
• Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration

  2017cites this paper
• Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.

  2016cites this paper
• Syntheses and antiproliferative effects of D-homo- and D-secoestrones.

  2014cites this paper
• Synthesis of novel 16-spiro steroids: 7-(Aryl)tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazolo estrone hybrid heterocycles.

  2014cites this paper
• The relationship between HIF-1α and autophagy activity in the hypoxic environment of breast cancer

  2013cites this paper
• Molecular crosstalk between apoptosis and autophagy induced by a novel 2-methoxyestradiol analogue in cervical adenocarcinoma cells

  2013cites this paper
• Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.

  2012cites this paper
• Organic synthetic environmental endocrine disruptors: structural classes and metabolic fate.

  2012cites this paper
• Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol.

  2012cites this paper
• Taxol alleviates 2-methoxyestradiol-induced endothelial permeability.

  2012cites this paper
• Molecular crosstalk between apoptosis and autophagy induced by a 2-methoxyestradiol analogue (C19) in HeLa cells

  2012cites this paper
• Cellular Targets and Tumour  Suppressive Mechanisms  of Peloruside A

  2012cites this paper
• Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogel

  2011cites this paper
• Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells

  2011influential citation
• Effects of Estrogen Metabolite 2-Methoxyestradiol on Tumor Suppressor Protein p53 and Proliferation of Breast Cancer Cells

  2011cites this paper
• 2-Methoxyestradiol--biology and mechanism of action.

  2010cites this paper
• The Measurement of Estrogens

  2010cites this paper
• Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells.

  2010cites this paper
• Mechanism of 2‐methoxyestradiol‐induced apoptosis and growth arrest in human breast cancer cells

  2009cites this paper
• Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.

  2009cites this paper
• The In vitro Sub-cellular Localization and In vivo Efficacy of Novel Chitosan/GMO Nanostructures containing Paclitaxel

  2009cites this paper
• Antiproliferative effects of 2-methoxyestradiol alone and in combination with chemotherapeutic agents on human endometrial cancer cells.

  2009cites this paper
• Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

  2009cites this paper
• Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells.

  2009cites this paper
• 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?

  2008cites this paper
• 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft

  2008cites this paper
• The Prostate 68 : 679 ^ 689 ( 2008 ) Potentiationof 2-Methoxyestradiol-Induced CytotoxicitybyBlocking EndothelinAReceptor in ProstateCancerCells

  2008cites this paper
• Potentiation of 2‐Methoxyestradiol‐Induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells

  2008cites this paper
• Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.

  2008cites this paper
• JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells

  2007influential citation
• Antiangiogenic Agents in Breast Cancer

  2007cites this paper
• 2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.

  2007cites this paper
• Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine.

  2007cites this paper
• [2-Methoxyestradiol -- a new compound for cancer treatment].

  2006cites this paper
• Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.

  2006cites this paper
• Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.

  2006cites this paper
• Estrogen Metabolite and Ligands of Death Receptor Family Pathways in Pancreatic Cancer : Synergistic Action of Crosstalk between Extrinsic and Intrinsic Cell Death

  2006cites this paper
• Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat

  2006cites this paper
• The Regional Distribution and Relative Frequency of Gastrointestinal Endocrine cells in the Nude Mice, Balb/c‐nu/nu: An Immunohistochemical Study

  2006cites this paper
• An immunohistochemical study of the pancreatic endocrine cells of the nude mouse, Balb/c-nu/nu.

  2006cites this paper
• Physiologic Levels of 2-Methoxyestradiol Interfere with Nongenomic Signaling of 17β-Estradiol in Human Breast Cancer Cells

  2006cites this paper
• Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.

  2006cites this paper
• 2-Methoxyestradiol als neue Substanz zur Krebstherapie

  2006cites this paper
• Changes of gastrointestinal argyrophil endocrine cells in the COLO205 tumor-implanted Balb/c-nu/nu mice.

  2005cites this paper
• Targeting hypoxia and angiogenesis through HIF-1alpha inhibition

  2005cites this paper